Leader in innovation for nutrition, Biofortis is a global CRO (Contract Research Organization) offering its expert services in nutrition – such as clinical trials, research projects, bioanalytical testing and sensory and consumer studies, to R&D professionals.
The geographical scope of Biofortis now extends to Europe, the USA, China and Brazil.
Biofortis attracts a large pharmaceutical group in Nantes.
It all started with the incubation and assistance-support from Atlanpole.
The keys to Biofortis development?
I can mention Atlanpole Biotherapies and Valorial clusters networking, the Round table with Ouest Ventures investors (October 2007), the help from Nantes Aménagement (i.e. a plot of land for the location of their headquarters), the financial support of the Region for the IMODI project (PSPC) and for the development of Biofortis meta-analysis platform, and finally the research projects with the university hospital teams, IFREMER, ONIRIS, INRA, ICO…
To be a leading CRO in supporting health innovation and personalized medicine.